Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.

MLA

Ye Sun, et al. “Nuclear Receptor RORα Regulates Pathologic Retinal Angiogenesis by Modulating SOCS3-Dependent Inflammation.” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 33, Aug. 2015, pp. 10401–06. EBSCOhost, https://doi.org/10.1073/pnas.1504387112.

APA

Ye Sun, Chi-Hsiu Liu, SanGiovanni, J. P., Evans, L. P., Tian, K. T., Bing Zhang, Stahl, A., Pu, W. T., Kamenecka, T. M., Solt, L. A., & Jing Chen. (2015). Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation. Proceedings of the National Academy of Sciences of the United States of America, 112(33), 10401–10406. https://doi.org/10.1073/pnas.1504387112

Chicago

Ye Sun, Chi-Hsiu Liu, John Paul SanGiovanni, Lucy P. Evans, Katherine T. Tian, Bing Zhang, Andreas Stahl, et al. 2015. “Nuclear Receptor RORα Regulates Pathologic Retinal Angiogenesis by Modulating SOCS3-Dependent Inflammation.” Proceedings of the National Academy of Sciences of the United States of America 112 (33): 10401–6. doi:10.1073/pnas.1504387112.